Study Finds No Risk of Coronavirus in Offspring Born to Infected Mothers
Researchers sought to evaluate the clinical characteristics of the 2019 novel coronavirus disease in pregnancy and assess transmission potential of the infection to newborns.
Women’s Health
Double-Dose Influenza Vaccine Doses May Not Benefit Pregnant Women With HIV
A double-dose of inactivated influenza vaccine may not increase the immunogenicity of the vaccine among pregnant women with HIV.
Ebola Virus RNA May Persist in Semen, Breast Milk for Longer Than Anticipated
Data from a large sample of Ebola survivors confirmed the persistence of Ebola viral RNA in semen for up to 6 months.
No Major Differences Between Outcomes in Pregnant Women Linked to ART Regimens
There are no major differences in pregnancy outcomes for women with HIV related to receipt of protease inhibitors, non-nucleoside reverse transcriptase inhibitors, or integrase strand transfer inhibitors.
Surveillance Estimates Prevalence of Neural Tube Defects in Births to Women With HIV
The prevalence of neural tube defects (NTDs) in births to mothers with HIV from 2013 to 2017 was estimated to be 7.0 per 10,000 live births.
Bivalent HPV Vaccine Induces Robust Serologic Response Nine Years Postvaccination
In addition to high antibody levels, factors including exposure to the human papillomavirus (HPV) and antibody avidity may be important and necessary to protect against infection.
Revogene LB Assay Noninferior to GeneXpert Assay in Detecting GBS
Both the Revogene GBS LB and GeneXpert GBS LB assays perform well for the detection of Group B Streptococcal (GBS) infections in pregnant women.
Discordance Between ART Prescribing Practices and Guidelines in Pregnant Women
Data published in JAMA Network Open suggest that prescribing practices of antiretroviral therapy (ART) in pregnant women living with HIV in the United States do not align optimally with national guidelines. In this prospective cohort study including data from 1867 pregnancies in 1582 women living with HIV, 49.5% were associated with prescribed ART designated as…
Many Pelvic Exams, Pap Tests Unnecessary in Teenagers and Young Adults
More than half of bimanual exams, >70 percent of Pap tests in women aged 15 to 20 years unnecessary
Protection Similar With Single, Multiple HPV Vaccine Doses
US women who have received one dose of HPV vaccine have similar protection as women who have received two or three doses.
Next post in Prevention
